Small Stocks, Big Money™

Zomedica’s (NYSE American: ZOM) PulseVet system was named the "Official Shock Wave of the USEA" for 2024 by the United States Eventing Association. The USEA is dedicated to advancing the sport of eventing through education of riders, trainers, officials, and organizers, with the health and well-being of the horse of paramount importance. As part of this partnership, Zomedica’s PulseVet will sponsor several high-profile events, including the USEA American Eventing Championships and the USEA Classic Series. PulseVet's electro-hydraulic shock wave technology, which promotes healing in equine, canine, and feline patients, will support the health and performance of event horses. This collaboration highlights Zomedica's commitment to advancing veterinary care, with the total U.S. market for PulseVet devices estimated at $1 billion.

LOBO EV Technologies (Nasdaq: LOBO) is set to open a new office in Wanica, Suriname, to strengthen its presence in the rapidly growing Latin American market. Partnering with Zhongda International Engineering Company, the new 2,152 square foot office and 5,381 square foot warehouse will support operations in the region and act as a distribution center. The collaboration will also provide LOBO access to over 107,639 square feet of land for potential assembly plant development. This strategic move aims to meet the rising demand for sustainable electric mobility solutions across the region.

Calidi Biotherapeutics (NYSE American: CLDI) was granted a new U.S. patent for its SuperNova technology platform, bolstering its intellectual property as it prepares to advance its CLD-201 program into clinical trials. U.S. Patent No. 12,036,278, titled "Smallpox Vaccine for Cancer Treatment," covers Calidi’s innovative use of adipose-derived mesenchymal stem cells loaded with oncolytic vaccinia virus. This patent includes methods and compositions combining a smallpox vaccine with stem cells, significantly expanding the platform’s potential. CEO Allan Camaisa highlighted this milestone as pivotal for developing treatments for advanced solid tumors. The patent strengthens Calidi’s position to deliver transformative cancer therapies.

Phoenix Motor’s (Nasdaq: PEV) PhoenixEV delivered five 40' ZX5 battery electric buses to the University of California, Irvine (UCI) in May 2024, enhancing UCI’s sustainable transportation system. UCI, the first university to adopt an all-electric fleet in 2018, now has 25 electric buses, having logged over 1.18 million miles and served 1.46 million riders in the 2023-24 academic year. The buses, charged via UCI’s microgrid, offer significant cost savings at $0.37 per mile compared to $1.53 for diesel. PhoenixEV’s CEO, Denton Peng, praised UCI's commitment to sustainability and their strategic partnership. This collaboration underscores PhoenixEV's growth in the educational market and UCI's leadership in reducing greenhouse gas emissions.